Microbiome Movement Drug Development Europe 2019

Microbiome Movement Drug Development Europe 2019

Meet our Business Development Managers Personal Care & Health Nils Hijlkema and Ioana Iorga  at the 3rd Microbiome Movement Drug Development Europe!

Despite the scientific communities progress in translating microbiome R&D into promising therapeutic candidates, academic and pharmaceutical leaders continue to identify the causal role of the human microbiome in disease to create treatments with consistent clinical outcomes and predictable molecular mechanisms. Part of the established Microbiome Movement, the 3rd Microbiome Movement – Drug Development Europe returns as the industry-defining forum to help discover, develop and deliver the next generation of microbiome-based therapeutic and diagnostic candidates to market.

On first day of this congress, at 3.00 PM, during ‘stream B: Clinical & Commercialisation‘, our Expertise Group Leader Fermentation, Herwig Bachmann, will update you on Genome based comparison and interpretation for the development of microbiome-based therepeutic products.

This congress will take place in Paris, from the 28th till the 30th of January 2019.